Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute (BA, MM, SL, SVA), USA.
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (DKT, JY, RGC, ZGG, KAJ), National Institutes of Health, Bethesda, MD, 20892, USA.
Eur J Med Chem. 2022 Mar 5;231:114103. doi: 10.1016/j.ejmech.2022.114103. Epub 2022 Jan 10.
Various adenosine receptor nucleoside-like ligands were found to modulate ATP hydrolysis by the multidrug transporter ABCG2. Both ribose-containing and rigidified (N)-methanocarba nucleosides (C2-, N- and 5'-modified), as well as adenines (C2-, N-, and deaza modified), were included. 57 compounds out of 63 tested either stimulated (50) or inhibited (7) basal ATPase activity. Structure-activity analysis showed a separation of adenosine receptor and ABCG2 activities. The 7-deaza modification had favorable effects in both (N)-methanocarba nucleosides and adenines. Adenine 37c (MRS7608) and (N)-methanocarba 7-deaza-5'-ethyl ester 60 (MRS7343) were found to be potent stimulators of ABCG2 ATPase activity with EC values of 13.2 ± 1.7 and 13.2 ± 2.2 nM, respectively. Both had affinity in the micromolar range for A adenosine receptor and lacked the 5'-amide agonist-enabling group (37c was reported as a weak A antagonist, K 6.82 μM). Compound 60 significantly inhibited ABCG2 substrate transport (IC 0.44 μM). Docking simulations predicted the interaction of 60 with 21 residues in the drug-binding pocket of ABCG2.
多种腺苷受体核苷类似配体被发现可调节多药转运体 ABCG2 对 ATP 的水解。包含核糖和刚性(N)-甲撑卡巴核苷(C2-、N-和 5'-修饰)以及腺嘌呤(C2-、N-和去氮修饰)。在所测试的 63 种化合物中有 57 种要么刺激(50 种)要么抑制(7 种)基础 ATPase 活性。结构活性分析表明,腺苷受体和 ABCG2 活性可以分开。7-脱氮修饰对(N)-甲撑卡巴核苷和腺嘌呤均有有利影响。腺嘌呤 37c(MRS7608)和(N)-甲撑卡巴 7-脱氮-5'-乙基酯 60(MRS7343)被发现是 ABCG2 ATPase 活性的有效刺激剂,EC 值分别为 13.2±1.7 和 13.2±2.2 nM。两者对 A 腺苷受体均具有亲和力,处于微摩尔范围内,并且缺乏 5'-酰胺激动剂使能基团(37c 被报道为弱 A 拮抗剂,K 6.82 μM)。化合物 60 显著抑制 ABCG2 底物转运(IC 0.44 μM)。对接模拟预测了 60 与 ABCG2 药物结合口袋中的 21 个残基的相互作用。